首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1522904

全球快速微生物检测市场规模、份额和成长分析：按产品、按应用、按方法、按地区 - 产业预测，2024-2031 年

Global Rapid Microbiology Testing Market Size, Share, Growth Analysis, By Product, By Application, By Method, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球快速微生物检测市场规模为42亿美元，从2023年的45.9亿美元增加至2031年的94.3亿美元，复合年增长率预计为9.4%。

由于几个关键因素，全球快速微生物检测市场正在经历强劲成长。其主要驱动力是人们对食品安全的日益关注，推动了对可靠检测方法的需求。技术的进步以及公共和私营部门投资的增加进一步支持了市场的扩张。另一个重要趋势是越来越多地使用微生物检测来诊断人类感染疾病，这凸显了早期、准确的疾病检测的必要性。研究活动的活性化，加上感染疾病率的上升和持续的技术创新，正在推动市场的快速发展。此外，政府致力于检测抗菌素抗药性的努力正在创造新的机会，特别是在新兴经济体。此外，全球对生物恐怖主义监测的关注正在为全球快速微生物检测市场开闢新的前景。这些多样化的成长轨迹凸显了该市场在解决全球对食品安全、感染疾病和增强诊断能力的担忧方面发挥的关键作用。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Thermo Fisher Scientific Inc.（United States）
bioMerieux SA（France）
Danaher Corporation（United States）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
3M Company（United States）
Abbott Laboratories（United States）
Bruker Corporation（United States）
Neogen Corporation（United States）
Quidel Corporation（United States）
Eurofins Scientific（Luxembourg）
F. Hoffmann-La Roche Ltd（Switzerland）
Cepheid Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Pall Corporation（United States）
BioFire Diagnostics, LLC（United States）
MilliporeSigma（United States）
Agilent Technologies, Inc.（United States）
Accelerate Diagnostics, Inc.（United States）
Luminex Corporation（United States）

简介目录

Product Code: SQMIG35A2782

Rapid Microbiology Testing Market size was valued at USD 4.20 billion in 2022 and is poised to grow from USD 4.59 billion in 2023 to USD 9.43 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The rapid microbiology testing market is experiencing robust growth due to several pivotal factors. Primary among these is the growing concern over food safety, which is boosting the demand for reliable testing methodologies. Technological advancements and increased investments from both public and private sectors are further bolstering market expansion. Another significant trend is the rising use of microbiology testing in diagnosing infectious diseases in humans, underscoring the need for early and accurate disease detection. Increased research activities, combined with rising incidences of infectious diseases and ongoing technological innovations, are driving rapid market evolution. Moreover, government initiatives, particularly in emerging economies, focusing on detecting antimicrobial resistance are creating new opportunities. Additionally, global attention on bioterrorism surveillance is opening up fresh prospects for the rapid microbiology testing market in the foreseeable future. This diverse growth trajectory highlights the market's pivotal role in addressing global concerns related to food safety, infectious diseases, and enhancing diagnostic capabilities worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Microbiology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Rapid Microbiology Testing Market Segmental Analysis

Rapid Microbiology Testing Market is segmented on the basis of product, method, application, and region. Based on product, the market is segmented into Instruments (Automated Microbial Identification & Antimicrobial Susceptibility Testing System, Mass Spectrometers, PCR Systems, Bioluminescence & Fluorescence Based Detection Systems, Cytometers, Active Air Samplers, and Other Instruments), Reagents & Kits (Sterility Testing, Other Reagents & Kits), and Consumables. Based on method, the market is segmented into Growth-based Rapid Microbiology Testing, Cellular Component -based Rapid Microbiology Testing, Nucleic Acid -based Rapid Microbiology Testing, Viability -based Rapid Microbiology Testing, Other Rapid Microbiology Testing. Based on application, the market is segmented into Industrial Testing (Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics & Personal Care Products Testing, Other Industrial Testing Applications), Clinical Disease Diagnosis, and Research Applications. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Rapid Microbiology Testing Market

The increase in infectious diseases worldwide, including global epidemics and pandemics like Pneumonia, has significantly boosted the demand for diagnostic tests. This rise in disease prevalence has heightened public consciousness and underscored the importance of early detection. Consequently, there is a growing recognition of the vital role diagnostic tests play in identifying and managing infectious diseases, driving a notable surge in demand for these tools. This heightened awareness, combined with proactive measures for early disease identification, is expected to fuel substantial growth in the diagnostic testing industry in the foreseeable future.

Restraints in the Rapid Microbiology Testing Market

The advancement of diagnostic tests, especially for cancer and infectious diseases, requires significant financial commitment, primarily to adhere to stringent regulatory standards. The dynamic field of diagnostic technologies and increasingly rigorous regulatory criteria necessitate substantial financial backing at every stage of clinical trials. The intensified regulatory oversight and the imperative to meet stringent criteria introduce delays in development, thereby demanding substantial investments to successfully navigate clinical trials complexities and obtain necessary regulatory endorsements.

Market Trends of the Rapid Microbiology Testing Market

Emerging economies like India, South Korea, Brazil, and Mexico offer significant growth opportunities for market participants. These markets are appealing due to several factors: high disease prevalence, large patient bases, improving healthcare infrastructure, increasing disposable incomes, and a growing trend in medical tourism. The substantial disease burden in these regions highlights the demand for advanced healthcare solutions, encompassing both diagnostic and therapeutic innovations. Ongoing enhancements in healthcare infrastructure also promote the uptake of new medical technologies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Global Rapid Microbiology Testing Market by Product

Market Overview
Instruments
- Automated Microbial Identification & Antimicrobial Susceptibility Testing System
- Mass Spectrometers
- PCR Systems
- Bioluminescence & Fluorescence Based Detection Systems
- Cytometers
- Active Air Systems
- Others
Reagents & Kits
- Sterility Testing & Kits
- Other Reagents & Kits
Consumables

Global Rapid Microbiology Testing Market by Application

Market Overview
Clinical Disease Diagnosis
Food and Beverage Testing
Pharmaceutical and Biological Drug Testing
Environmental Testing
Cosmetics and Personal Care Products Testing
Research Applications
Othersa

Global Rapid Microbiology Testing Market by Method

Market Overview
Growth-based Rapid Microbiology Testing
Cellular Component -based Rapid Microbiology Testing
Nucleic Acid -based Rapid Microbiology Testing
Viability -based Rapid Microbiology Testing
Other Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioFire Diagnostics, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MilliporeSigma (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accelerate Diagnostics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments